Loading…
Lobbying Spend
—
Filings
14
Firms Hired
1
Active Period
2019–2021
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lower Health Care Costs Act
2020 · fourth_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD). Issues related to COVID-19.
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2020 · fourth_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2020 · third_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $30,000
Matched citations: S.1895
Lower Health Care Costs Act
2020 · third_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD). Issues related to COVID-19.
Client expense: — · Firm income: $30,000
Matched citations: S.1895
Lower Health Care Costs Act
2020 · second_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD). Issues related to COVID-19.
Client expense: — · Firm income: $50,000
Matched citations: S.1895
Lower Health Care Costs Act
2020 · second_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $50,000
Matched citations: S.1895
Lower Health Care Costs Act
2020 · first_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: —
Matched citations: S.1895
Lower Health Care Costs Act
2020 · first_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: —
Matched citations: S.1895
Lower Health Care Costs Act
2019 · fourth_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: —
Matched citations: S.1895
Lower Health Care Costs Act
2019 · fourth_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: —
Matched citations: S.1895
Lower Health Care Costs Act
2019 · fourth_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · fourth_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · third_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · third_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $10,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $10,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Firm: TAUZIN STRATEGIC NETWORKS
Issues related to combating the opioid epidemic; drug costs; S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act
Client expense: — · Firm income: $10,000
Matched citations: S.1895
Source: Senate LDA